Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

WF 10

Next Previous
Search
Drug Profile

WF 10

Alternative Names: IMMUNOKINE; OXO-K993; TCDO; Tetrachlorodecaoxide; Tetrachlorodecaoxygen; WF10

Latest Information Update: 27 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nuvo Research
  • Developer Crescita Therapeutics; Fraunhofer Institute for Molecular Biology and Applied Ecology; Nuvo Research
  • Class Halogens; Oxides
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diabetic foot ulcer; Radiation injuries
  • No development reported Cancer; Rheumatoid arthritis
  • Discontinued Allergic rhinitis; Hepatitis C; HIV infections

Most Recent Events

  • 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
  • 21 Dec 2015 Discontinued - Phase-II for Allergic rhinitis (In the elderly, In adults) in Germany (IV)
  • 21 Dec 2015 Discontinued - Phase-II for Allergic rhinitis in Canada (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top